clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT01823783 |
P17 | country | France | Q142 |
P582 | end time | 2018-06-01 | |
P4135 | maximum age | 15 | |
P2899 | minimum age | 2 | |
P1132 | number of participants | 50 | |
P4844 | research intervention | calcium oxalate | Q412399 |
P6153 | research site | University of Bordeaux | Q13344 |
Necker–Enfants Malades Hospital | Q3145188 | ||
University of Lille | Q3551621 | ||
Rangueil Hospital | Q18745239 | ||
Montpellier University Hospital | Q19859682 | ||
P580 | start time | 2012-11-07 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Endomysial Fibrosis, Muscular Inflammatory Response and Calcium Homeostasis Dysfunction : Potential Links and Targeted Pharmacotherapy in Duchenne Muscular Dystrophy (DMD). |
Search more.